| Date Filed | Type | Description |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| ROWLAND LLOYD A (General Counsel) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 22,500 shares
@ $0
Granted 135,000 options to buy
@ $4.13, valued at
$557.6k
|
|
| 10/26/2021 |
4
| ROWLAND LLOYD A (General Counsel) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.34, valued at
$213.6k
Granted 30,000 options to buy
@ $0 |
|
| 03/02/2021 |
4
| ROWLAND LLOYD A (General Counsel) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $7.85, valued at
$981.3k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| ROWLAND LLOYD A (General Counsel) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 1,812 shares
@ $8.211, valued at
$14.9k
|
|
| 03/05/2019 |
4
| ROWLAND LLOYD A (General Counsel) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Bought 9,000 shares
@ $10.33, valued at
$93k
|
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| ROWLAND LLOYD A (General Counsel) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 979 shares
@ $11.73, valued at
$11.5k
|
|
| 06/15/2018 |
3
| ROWLAND LLOYD A (General Counsel) has filed a Form 3 on CytomX Therapeutics, Inc. |
| 01/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/21/2015 |
4
| ROWLAND LLOYD A (Sr. V.P. and General Counsel) has filed a Form 4 on Xencor Inc|
Txns:
| Acquired 1,501 shares
@ $0 |
|
| 03/20/2015 |
4
| ROWLAND LLOYD A (Sr. V.P. and General Counsel) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 25,000 options to buy
@ $15.99, valued at
$399.8k
|
|
| 02/13/2015 |
4
| ROWLAND LLOYD A (Sr. V.P. and General Counsel) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 12,500 options to buy
@ $15.69, valued at
$196.1k
|
|
| 09/02/2014 |
4
| ROWLAND LLOYD A (Sr. V.P. and General Counsel) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 60,000 options to buy
@ $10.69, valued at
$641.4k
|
|
| 08/10/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/26/2012 |
4
| ROWLAND LLOYD A (VP, Chief Compliance Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Granted 823 shares
@ $14.62, valued at
$12k
|
|
| 03/29/2012 |
4
| ROWLAND LLOYD A (VP, Chief Compliance Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $22.83, valued at
$114.2k
Sold 3,000 shares
@ $25, valued at
$75k
Exercised 5,000 options to buy
@ $9.02, valued at
$45.1k
|
|
| 03/07/2012 |
4
| ROWLAND LLOYD A (VP, Chief Compliance Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Granted 6,700 shares
@ $0
Granted 1,529 shares
@ $0
Granted 7,802 options to buy
@ $16.02, valued at
$125k
Granted 12,198 options to buy
@ $16.02, valued at
$195.4k
|
|
| 03/02/2012 |
4
| ROWLAND LLOYD A (VP, Chief Compliance Officer) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC|
Txns:
| Disposed/sold 1,767 shares
@ $0
Granted 1,767 options to buy
@ $0 |
|
| 02/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2009 |
4
| ROWLAND LLOYD A (VP Governance Compliance & Cor) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC |
| 02/05/2009 |
4
| ROWLAND LLOYD A (VP Governance Compliance & Cor) has filed a Form 4 on AMYLIN PHARMACEUTICALS INC |